Expert consensus on pharmaceutical services for clinical applications of innovative subcutaneous prepara-tions of antineoplastic drugs
In recent years,with a rapid development of subcutaneous drug delivery techniques,more and more antineoplastic monoclonal antibodies of existing intravenous agents have been approved for subcutaneous dosing.Pharmaceutical manufacturing,pharmacokinetic characteristics,clinical efficacy and safety,clinical rational use and pharmaceutical management of innovative sub-cutaneous antineoplastic drugs have attracted growing attention.However,there is still a global lack of normative guidance for inno-vative subcutaneous antineoplastic drugs.Therefore,Hospital Pharmacy Specialty Committee of Chinese Pharmaceutical Associa-tion organized domestic experts to propose the definition of innovative subcutaneous preparations of antineoplastic drugs based upon existing resources of evidence-based medicine and clinical drug dosing experiences.Recommendations were offered on unique char-act eristics,clinical rational use,pharmaceutical management and care of innovative subcutaneous antineoplastic drugs.
NETL
NSTL
万方数据
